Stock data
Faeth Therapeutics, Inc. (FTH)
Faeth Therapeutics, Inc. (FTH) reported net income of -US$21.09M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$22.29M | -US$21.09M | — |
| 2024 | — | — | -US$32.61M | -US$30.16M | — |
| 2023 | — | — | -US$37.06M | -US$34.10M | — |
| 2022 | — | — | -US$50.19M | -US$48.59M | — |
| 2021 | — | — | -US$37.48M | -US$36.79M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$16.01M | — |
| 2026-03-31 | — | -US$170.24M | — |
| 2025-12-31 | — | -US$4.72M | — |
| 2025-09-30 | — | -US$4.57M | — |
| 2025-06-30 | — | -US$4.94M | — |
| 2025-03-31 | — | -US$6.86M | — |
| 2024-12-31 | — | -US$7.77M | — |
| 2024-09-30 | — | -US$7.25M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.